Schedule 13G ownership disclosure

VERTEX PHARMACEUTICALS INC COM

Security class unavailable · CUSIP: 92532F100

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,705,746
Percent of class
2.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000053417-15-000135
Form type
SC 13G/A
Filer
JENNISON ASSOCIATES LLC
CIK
CIK 53417
Filed
Feb 10, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub